A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2018
At a glance
- Drugs Bisoprolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms Biso-CHF Study
- Sponsors Merck KGaA
- 31 Aug 2018 Biomarkers information updated
- 16 May 2018 Planned primary completion date changed from 31 Jan 2019 to 31 Jan 2020.
- 12 Jan 2018 Planned End Date changed from 31 Jan 2019 to 31 Jan 2020.